Not Signed In - Antidepressant Mirtazapine To Be Submitted For Approval In Japan, Earlier Than Expected
Sun, 14 Jan 2007 12:00 AM EST
... Organon, the human healthcare business unit of Akzo Nobel - announced today that it anticipated filing a new drug application for its novel antidepressant mirtazapine (known as Remeron® in most countries) to Japanese health authorities (PMDA) towards the middle of 2007, three years earlier than expected. [click link for full article] ...
Related Topics
- Mirtazapine
- Usher Syndrome: New Insights Lead to Earlier Treatment
- Vaccine Testing & Approval
- Japan
- Antidepressant Medications
- Antidepressant Medications, Tricyclics
- Antidepressant Medications, SSRIs
- U.S.- Japan Cooperative Medical Science Program: Sixth Five Year Report
- Procedures and Therapies
- Tarceva
- Travel
- Culture
- Winter Storms
- Trazodone
- Escitalopram
- Atomoxetine
- BSE
- Duloxetine
- Earthquakes
- Citalopram
email this page
print this page
bookmark this page
feedback on this page
